Let's Talk About It: Breast Cancer
This is a new format and category to open up monthly programming for the entire early-stage breast cancer community. Some topics will be broad and others will be specific to subtype (TNBC, DCIS, ILC, IBC, Inflammatory). We want to encourage discussion and foster community.
The group is a hybrid between an educational webinar, where a healthcare professional will speak on one topic, and the intimacy of a support group where personal stories can be shared and are a big part of the conversation.
March 21: Cutting-Edge Research on Triple-Negative Breast Cancer (TNBC)
Researchers from the University of Arizona have developed a drug compound that appears to stop cancer cell growth in what's known as triple-negative breast cancer. The drug, which has not yet been tested in humans, has been shown to eliminate tumors in mice, with little to no effect on normal healthy cells, making it potentially nontoxic for patients. The therapy is based on a newly discovered way that a gene known as epidermal growth factor receptor, or EGFR, leads to cancer. EGFR is a long-investigated oncogene—a gene that in certain circumstances can transform a cell into a tumor cell. Join our facilitator Nancy Touhill as she speaks with a researcher to breakdown this information for the TNBC community.
CANCELLED - To be Rescheduled for a later Date - Part 1: Chemo Education - The History and Why Chemo Is Often Part of Cancer Treatment
Did you know chemotherapy was established for early-stage breast cancer in the 1980s? Chemo was first developed at the beginning of the 20th century but was not originally intended as a cancer treatment until World War II. Join our speaker Sara Horton, MD, the Executive Director, of Access and Diversity at Quantum Leap Healthcare Collaborative, and learn about the evolution of cancer chemotherapy and how it became used in breast cancer.
May 16: Chemotherapy Tips from Cancer Patients Who’ve Been There
Every person experiences chemotherapy differently, both physically and emotionally. Each can also experience different side effects depending on their treatment protocol.
June 20: The History and Advances in Radiation Therapy
We know that radiation therapy (RT) is an important component of breast cancer treatment that reduces local recurrence and improves survival after breast conservation. Have you ever wondered about the history of radiation and the role of radiation boosts to the primary tumor site? How do radiation oncologists determine who should receive radiation therapy or not? Join us as we discuss the history and advances in radiation therapy with Karen Godette, MD, Medical Director of the Radiation Oncology Department at Emory University Hospital Midtown in and Associate Professor, Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA.
Register to get instructions to join.